Shanghai RAAS Blood Products Co., Ltd.

SZSE:002252 Stock Report

Market Cap: CN¥45.4b

Shanghai RAAS Blood Products Management

Management criteria checks 1/4

Shanghai RAAS Blood Products' CEO is Jun Xu, appointed in Oct 2022, has a tenure of 2.25 years. directly owns 0.018% of the company’s shares, worth CN¥8.38M. The average tenure of the management team and the board of directors is 8.3 years and 0.5 years respectively.

Key information

Jun Xu

Chief executive officer

CN¥6.5m

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownership0.02%
Management average tenure8.3yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Jun Xu (60 yo)

2.3yrs

Tenure

CN¥6,506,900

Compensation

Mr. Jun Xu serves as General Manager at Shanghai RAAS Blood Products Co., Ltd. since October 19, 2022 and served as its Deputy General Manager until October 19, 2022. He served as General Manager of Shangh...

Leadership Team

NamePositionTenureCompensationOwnership
Jun Xu
GM & Chairman2.3yrsCN¥6.51m0.018%
CN¥ 8.4m
Leqi Chen
Financial Manager3.3yrsCN¥3.66m0.00076%
CN¥ 345.3k
Zheng Liu
Deputy GM & Secretary of Board of Directors17.8yrsCN¥4.35m0.012%
CN¥ 5.3m
Ji Hui Shen
Deputy General Manager20.7yrsCN¥4.19m0.010%
CN¥ 4.7m
Hui Lu
Deputy General Manager11.8yrsCN¥4.20m0.0083%
CN¥ 3.8m
Zhengmin Song
Deputy General Manager4.7yrsCN¥4.19m0.0034%
CN¥ 1.5m
Xi Zhao
Head of Accountingno datano datano data
Yang Gu
Director of Sales & Marketingno datano datano data

8.3yrs

Average Tenure

55yo

Average Age

Experienced Management: 002252's management team is seasoned and experienced (8.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jun Xu
GM & Chairman8.8yrsCN¥6.51m0.018%
CN¥ 8.4m
Hoang Binh
Member of the Supervisory Board17.9yrsCN¥238.10kno data
Wei Bing Hu
Chairman of the Supervisory Board4.7yrsCN¥2.15m0.012%
CN¥ 5.4m
Yao Li
Member of the Supervisory Board17.9yrsCN¥238.10kno data
Amarant Martinez Carrio
Non-Independent Directorless than a yearno datano data
Xiangrui Bu
Independent Directorless than a yearno datano data
Deguo Zhan
Non-employee Supervisorless than a yearno datano data
Jihui Jia
Independent Directorless than a yearno datano data
Congqi Gu
Non- Independent Directorless than a yearno datano data
Ying Hong
Independent Directorless than a yearno datano data
Quanli Wang
Non-Independent Directorless than a yearno datano data
Lixia Tan
Non-Independent Directorless than a yearno datano data

0.5yrs

Average Tenure

60yo

Average Age

Experienced Board: 002252's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 11:42
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai RAAS Blood Products Co., Ltd. is covered by 16 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Pei ChengChina Galaxy Securities Co., Ltd.
Shanshan LiChina Merchants Securities Co. Ltd.